Home › Funds › Parkman Healthcare Partners LLC › STOK
Parkman Healthcare Partners LLC position in STOK
STOKE THERAPEUTICS INC · Health Care
Parkman Healthcare Partners LLC reported holding 355,443 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.6M, representing 1.19% of its reported portfolio and ranking #33 among its reported holdings. Parkman Healthcare Partners LLC has disclosed STOK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's STOK position evolved
Parkman Healthcare Partners LLC first disclosed a stake in STOK in Q3 2025 at 250,000 shares (US$5.9M). The position peaked in Q4 2025 at 430,155 shares, worth US$13.7M. Across 4 filings, Parkman Healthcare Partners LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 355,443 shares valued at US$11.6M — an increase of 18,924 shares quarter over quarter.. Notable position changes include a 72% increase in Q4 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 250.00K | $5.88M | New |
| Q4 2025 | 430.15K | $13.65M | Add |
| Q1 2026 | 336.52K | $10.96M | Reduce |
| Q2 2026 | 355.44K | $11.63M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- Siren, L.L.C. 2.00M sh · $65.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- EcoR1 Capital, LLC 735.00K sh · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held STOK?
Parkman Healthcare Partners LLC has disclosed STOK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Parkman Healthcare Partners LLC's current position in STOK?
As of Q2 2026, Parkman Healthcare Partners LLC holds 355.44K shares of STOK (STOKE THERAPEUTICS INC), valued at $11.63M, representing 1.19% of its reported portfolio and ranking #33.
Has Parkman Healthcare Partners LLC been buying or selling STOK?
In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC increased its position in STOK. The position peaked in Q4 2025 at 430.15K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.